UAE-Based The Black Box Announces Project Pipeline Exceeding USD 10 Million Following Participation at Make it in the Emirates 2026 
Lerner & Rowe Gives Back to Host 5th Annual Cornhole Tournament on May 9 in Crown Point, Indiana 
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition 
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals 
MK International Achieves ASEAN & Asia Records for Proprietary Quantum Molecular Technology Spray Series Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development…
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
Scopus BioPharma to Present at the LD Micro Main Event
Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology…
Albireo Recognizes PFIC Awareness Day 2021
BOSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare pediatric…
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both…
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
NEW YORK and SCOTTSDALE, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey…
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
SAN DIEGO, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”),…
Better Choice Announces Participation in Upcoming Investor Conferences in October 2021
NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (the “Company”…
Outlook Therapeutics to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Outlook Therapeutics senior leadership team to provide a company overview and participate on industry panel…
Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference
HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
Experienced commercial leader brings 20 years of experience in pharma PRINCETON, N.J., Oct. 05, 2021…
Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings
– Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS…
VYNE Therapeutics Announces its China Partner’s Enrollment of First Patient in Phase 3 Study of AMZEEQ® in Patients with Moderate to Severe Acne
BRIDGEWATER, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential Anti-Anxiety Activity via Peripheral Nasal Neurons without Entry into the Brain
Preclinical study of intranasal radiolabeled PH94B in laboratory rats further differentiates PH94B’s mechanism of action…
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
WATERTOWN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced…
VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States
Amos Ron to Retire as CFO and Will Continue to Serve as Corporate Secretary, Advisor…
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from Pooled Donor Cells
Nes-Ziona, Israel, Oct. 05, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial
– UDENYCA® On-Body Injector (OBI) Achieved Both Pharmacokinetic and Pharmacodynamic Bioequivalence in Randomized Clinical Trial…
Akero Therapeutics to Present at the H.C. Wainwright 5th Annual NASH Investor Conference
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…
Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer
Industry veteran with decades of experience in company formation, scientific research, and drug development to…